Free Trial

Pulse Biosciences (PLSE) Competitors

Pulse Biosciences logo
$15.17 +0.18 (+1.20%)
Closing price 04:00 PM Eastern
Extended Trading
$15.20 +0.03 (+0.20%)
As of 04:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PLSE vs. TMDX, SLNO, NVST, LIVN, WRBY, INSP, LQDA, PRCT, LMAT, and AORT

Should you be buying Pulse Biosciences stock or one of its competitors? The main competitors of Pulse Biosciences include TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), Liquidia Technologies (LQDA), PROCEPT BioRobotics (PRCT), LeMaitre Vascular (LMAT), and Artivion (AORT). These companies are all part of the "medical equipment" industry.

Pulse Biosciences vs. Its Competitors

TransMedics Group (NASDAQ:TMDX) and Pulse Biosciences (NASDAQ:PLSE) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation, media sentiment and analyst recommendations.

TransMedics Group has a beta of 2.18, indicating that its stock price is 118% more volatile than the S&P 500. Comparatively, Pulse Biosciences has a beta of 1.68, indicating that its stock price is 68% more volatile than the S&P 500.

TransMedics Group presently has a consensus target price of $122.11, suggesting a potential upside of 17.36%. Pulse Biosciences has a consensus target price of $22.00, suggesting a potential upside of 45.02%. Given Pulse Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Pulse Biosciences is more favorable than TransMedics Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TransMedics Group
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.70
Pulse Biosciences
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

TransMedics Group has a net margin of 13.49% compared to Pulse Biosciences' net margin of 0.00%. TransMedics Group's return on equity of 28.02% beat Pulse Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
TransMedics Group13.49% 28.02% 8.64%
Pulse Biosciences N/A -63.19%-54.98%

TransMedics Group has higher revenue and earnings than Pulse Biosciences. Pulse Biosciences is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TransMedics Group$531.29M6.68$35.46M$1.9353.91
Pulse Biosciences$700K1,458.05-$53.58M-$1.05-14.45

99.7% of TransMedics Group shares are owned by institutional investors. Comparatively, 77.0% of Pulse Biosciences shares are owned by institutional investors. 7.0% of TransMedics Group shares are owned by insiders. Comparatively, 71.5% of Pulse Biosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, TransMedics Group had 12 more articles in the media than Pulse Biosciences. MarketBeat recorded 15 mentions for TransMedics Group and 3 mentions for Pulse Biosciences. Pulse Biosciences' average media sentiment score of 1.31 beat TransMedics Group's score of 1.03 indicating that Pulse Biosciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TransMedics Group
9 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Pulse Biosciences
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

TransMedics Group beats Pulse Biosciences on 12 of the 17 factors compared between the two stocks.

Get Pulse Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PLSE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PLSE vs. The Competition

MetricPulse BiosciencesMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.02B$6.87B$5.76B$9.91B
Dividend YieldN/A1.19%6.66%4.49%
P/E Ratio-14.4526.0683.0126.65
Price / Sales1,458.0570.72503.03163.66
Price / CashN/A22.4425.7028.92
Price / Book9.797.0410.796.52
Net Income-$53.58M$178.31M$3.29B$266.21M
7 Day Performance-2.51%-0.62%0.02%-0.76%
1 Month Performance0.66%1.87%7.06%3.83%
1 Year Performance-10.40%9.93%50.09%24.39%

Pulse Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PLSE
Pulse Biosciences
4.1177 of 5 stars
$15.17
+1.2%
$22.00
+45.0%
-12.3%$1.02B$700K-14.45140News Coverage
Positive News
TMDX
TransMedics Group
3.8921 of 5 stars
$114.97
-4.1%
$123.00
+7.0%
-32.9%$4.09B$531.29M59.57210Positive News
Analyst Forecast
SLNO
Soleno Therapeutics
4.5722 of 5 stars
$66.51
-3.0%
$115.09
+73.0%
+41.6%$3.64BN/A-16.0730News Coverage
Positive News
NVST
Envista
3.8084 of 5 stars
$21.15
-2.6%
$20.92
-1.1%
+13.9%$3.61B$2.55B66.1012,300Positive News
LIVN
LivaNova
1.9069 of 5 stars
$56.35
+0.8%
$59.71
+6.0%
+14.1%$3.05B$1.25B-14.492,900News Coverage
Positive News
Analyst Forecast
WRBY
Warby Parker
1.8004 of 5 stars
$26.18
-3.1%
$24.06
-8.1%
+81.6%$2.84B$771.32M-373.883,780News Coverage
Positive News
INSP
Inspire Medical Systems
4.9949 of 5 stars
$93.20
-2.9%
$165.62
+77.7%
-51.7%$2.84B$802.80M53.881,246Positive News
Analyst Forecast
Insider Trade
LQDA
Liquidia Technologies
3.4317 of 5 stars
$26.25
-2.2%
$32.11
+22.3%
+221.1%$2.31B$14M-15.4450News Coverage
Insider Trade
Options Volume
PRCT
PROCEPT BioRobotics
3.6519 of 5 stars
$39.31
-4.7%
$74.88
+90.5%
-49.6%$2.29B$224.50M-25.36430Positive News
Analyst Upgrade
LMAT
LeMaitre Vascular
3.2373 of 5 stars
$97.60
-2.7%
$97.60
+8.1%$2.27B$219.86M47.38490Positive News
AORT
Artivion
3.4668 of 5 stars
$43.53
-2.9%
$40.63
-6.7%
+65.0%$2.12B$388.54M-103.641,600Positive News

Related Companies and Tools


This page (NASDAQ:PLSE) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners